Ernexa Therapeutics Inc.: Form 8-K, filed Jul 19, 2021
Filed with the SEC on Jul 19, 2021 and accepted by EDGAR at Jul 19, 2021, 16:05 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 2.01 Completion of an acquisition or disposition
- Item 3.02 Unregistered sale of equity
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001140361-21-024732. Last ingested by Listed: Nov 11, 2026, 02:49 ET. Listed shows no prices and gives no investment advice.